NL-OMON53764招募中不适用
Implementation of up-front ctDNA analysis into lung cancer care and development of liquid biopsy-based decision support models - the Lungmarker2 study - LM2 study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 800
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •first work-up for suspected lung cancer
排除标准
- •Presence of another malignant tumor, i.e. diagnosed with a tumor in the past 5
研究者
相似试验
已完成
不适用
ongkankernet implementation ctDNA Analysisnon-small cell lung cancerLung cancerNL-OMON50777Radboud Universitair Medisch Centrum250
已完成
不适用
TLA Technology: a new DNA diagnostic test to sequence genes that cause the disease and detect new mutations: proof of concept study voor patients with Rendu-Osler-Weber disease.Rendu-Osler-Weber hereditary hemorrhagic telangiectasia10007510NL-OMON39779Sint Antonius Ziekenhuis45
进行中（未招募）
1 期
Single arm phase II study of ctDNA-guided encorafenib plus cetuximab retreatment in patients with BRAF V600E mutated mCRC. BRICKET studyCTIS2023-509088-26-00Gruppo Oncologico Del Nord Ovest16
招募中
不适用
Catch the cancer; towards a cfDNA-based test for colorectal cancer screening<p>Lynch syndrome, colorectal cancer</p>NL-OMON29451Erasmus MC150
已完成
不适用
Catch the cancer; towards a cfDNA-based test for colorectal cancer screeningcolorectal carcinoma100180181001799010017991colorectal cancerNL-OMON48193Erasmus MC, Universitair Medisch Centrum Rotterdam150